Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K/AKT pathway

• Main Authors: Yingzi He (Author), Zhiwei Zheng (Author), Chang Liu (Author), Wen Li (Author), Liping Zhao (Author), Guohui Nie (Author), Huawei Li (Author)
• Formato: Livro
• Publicado em: Elsevier, 2022-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Cisplatin-related ototoxicity is a critical side effect of chemotherapy and can lead to irreversible hearing loss. This study aimed to assess the potential effect of the DNA methyltransferase (DNMT) inhibitor RG108 on cisplatin-induced ototoxicity. Immunohistochemistry, apoptosis assay, and auditory...